Zydus receives final approval from USFDA to market Colestipol Hydrochloride tablets \
1 min read
\
\

Zydus receives final approval from USFDA to market Colestipol Hydrochloride tablets

15-Mar-2022
Ahmedabad (Gujarat) [India], March 15 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Colestipol Hydrochloride Tablets in the strength of 1mg (US RLD: Colestid), said the pharmaceutical company on Monday.
15-Mar-2022 National
\